BLPH Bellerophon Therapeutics Inc

Bellerophon Therapeutics Inc is a clinical-stage biotherapeutics company. It develops products that are focused on the treatment of various types of pulmonary hypertension disorder.

$4.71
As of 06/11/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/13/2015
Outstanding shares:  9,506,419
Average volume:  43,510
Market cap:   $43,444,335
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    078771300
ISIN:        US0787713009
Sedol:      BKTZS78
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   1.35
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy